Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma

Clinical trial NCT06151236 · RECRUITING

Trial details

NCT number: NCT06151236
Sponsor: Melanoma Institute Australia
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Merkel Cell Carcinoma

Start date: 2024-03-11
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.